![Evidence network for NMA of short-and long-term safety outcomes. A,... | Download Scientific Diagram Evidence network for NMA of short-and long-term safety outcomes. A,... | Download Scientific Diagram](https://www.researchgate.net/publication/349512466/figure/fig1/AS:1025672726200321@1621550842947/Evidence-network-for-NMA-of-short-and-long-term-safety-outcomes-A-Short-term-NMAs-The.png)
Evidence network for NMA of short-and long-term safety outcomes. A,... | Download Scientific Diagram
![Long-term safety for the final repository for spent nuclear fuel at Forsmark. Main report of the SR-Site project. Updated 2015-05 – SKB.com Long-term safety for the final repository for spent nuclear fuel at Forsmark. Main report of the SR-Site project. Updated 2015-05 – SKB.com](https://www.skb.com/publications/images/2345580/2345580-large.png)
Long-term safety for the final repository for spent nuclear fuel at Forsmark. Main report of the SR-Site project. Updated 2015-05 – SKB.com
![Long-term Safety Profile of Tenofovir Alafenamide in Chronic Hepatitis B Patients: Final 8-Year Results of 2 Phase 3 Studies Long-term Safety Profile of Tenofovir Alafenamide in Chronic Hepatitis B Patients: Final 8-Year Results of 2 Phase 3 Studies](https://www.natap.org/2023/images/070323/070323-4/0703231.gif)
Long-term Safety Profile of Tenofovir Alafenamide in Chronic Hepatitis B Patients: Final 8-Year Results of 2 Phase 3 Studies
![Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study - The Lancet Respiratory Medicine Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/asset/1f526b91-3fbe-4a60-adcb-7af7ee9e69f3/gr1a.jpg)
Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study - The Lancet Respiratory Medicine
![Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma - ScienceDirect Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0091674918314799-fx1.jpg)
Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma - ScienceDirect
Improving Operations and Long-Term Safety of the Waste Isolation Pilot Plant: Interim Report | The National Academies Press
![Long-term safety and efficacy of lumacaftor–ivacaftor therapy in children aged 6–11 years with cystic fibrosis homozygous for the F508del-CFTR mutation: a phase 3, open-label, extension study - The Lancet Respiratory Medicine Long-term safety and efficacy of lumacaftor–ivacaftor therapy in children aged 6–11 years with cystic fibrosis homozygous for the F508del-CFTR mutation: a phase 3, open-label, extension study - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/asset/01a97f20-3a60-4315-958b-8b7cead9932d/gr1.jpg)
Long-term safety and efficacy of lumacaftor–ivacaftor therapy in children aged 6–11 years with cystic fibrosis homozygous for the F508del-CFTR mutation: a phase 3, open-label, extension study - The Lancet Respiratory Medicine
![A Randomized, Placebo‐Controlled Phase III Extension Trial of the Long‐Term Safety and Tolerability of Anifrolumab in Active Systemic Lupus Erythematosus - Kalunian - 2023 - Arthritis & Rheumatology - Wiley Online Library A Randomized, Placebo‐Controlled Phase III Extension Trial of the Long‐Term Safety and Tolerability of Anifrolumab in Active Systemic Lupus Erythematosus - Kalunian - 2023 - Arthritis & Rheumatology - Wiley Online Library](https://acrjournals.onlinelibrary.wiley.com/cms/asset/02285399-8dcb-4be5-b327-4b77fa159ab2/art42392-toc-0001-m.jpg)